When Hims & Hers Health (NYSE: HIMS) reported Q1 FY2026 earnings on May 11, shareholders were dismayed by the magnitude of the double miss.
The telehealth platform reported an earnings per share (EPS) of negative 44 cents versus analyst expectations of four cents, and quarterly revenue of just over $608 million fell far short of the nearly $617 million consensus.